95 related articles for article (PubMed ID: 3358625)
1. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study.
Volm M; Mattern J; Müller T; Drings P
Anticancer Res; 1988; 8(1):105-12. PubMed ID: 3358625
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E
Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of independent cellular prognostic factors in squamous cell carcinoma of the lung].
Volm M; Kayser K; Mattern J
Strahlenther Onkol; 1989 Aug; 165(8):587-92. PubMed ID: 2772815
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.
Moran RE; Melamed MR
Anal Quant Cytol; 1984 Jun; 6(2):99-104. PubMed ID: 6205621
[TBL] [Abstract][Full Text] [Related]
5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology.
Ołszewski W; Darzynkiewicz Z; Claps ML; Melamed MR
Anal Quant Cytol; 1982 Jun; 4(2):90-8. PubMed ID: 6287892
[TBL] [Abstract][Full Text] [Related]
7. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
Volm M; Mattern J; Sonka J; Vogt-Schaden M; Wayss K
Cytometry; 1985 Jul; 6(4):348-56. PubMed ID: 2990835
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
Jeanfaivre T; Chassevent A; Larra F; Tuchais E
Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Gasiorowski L; Kaczmarek E
Lung Cancer; 2006 Feb; 51(2):201-6. PubMed ID: 16375987
[TBL] [Abstract][Full Text] [Related]
14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
Volm M; Kleine W
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048
[TBL] [Abstract][Full Text] [Related]
17. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].
Jeanfaivre T; Chassevent A; Geslin J; Larra F; Tuchais E
Bull Cancer; 1997 Jun; 84(6):597-602. PubMed ID: 9295862
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
